291 results on '"Yamanaka, Yoshitaka"'
Search Results
2. Sleep-related hypoventilation and hypercapnia in multiple system atrophy detected by polysomnography with transcutaneous carbon dioxide monitoring
3. The Japan MSA registry: A multicenter cohort study of multiple system atrophy
4. Differentiation between Parkinson’s Disease and the Parkinsonian Subtype of Multiple System Atrophy Using the Magnetic Resonance T1w/T2w Ratio in the Middle Cerebellar Peduncle
5. Electrogastrography for diagnosis of early-stage Parkinson's disease
6. Predicting Neurocognitive Change after Bilateral Deep Brain Stimulation of Subthalamic Nucleus for Parkinson's Disease
7. Monoamine oxidase B rs1799836 G allele polymorphism is a risk factor for early development of levodopa-induced dyskinesia in Parkinson's disease
8. Decline in drawing ability and cerebral perfusion in Parkinson's disease patients after subthalamic nucleus deep brain stimulation surgery
9. Coexistence of neuronal intranuclear inclusion disease and amyotrophic lateral sclerosis: an autopsy case
10. Predictive potential of preoperative electroencephalogram for neuropsychological change following subthalamic nucleus deep brain stimulation in Parkinson’s disease
11. The severity of motor dysfunctions and urinary dysfunction is not correlated in multiple system atrophy
12. Idiopathic cerebellar ataxia (IDCA): Diagnostic criteria and clinical analyses of 63 Japanese patients
13. Vertical pons hyperintensity and hot cross bun sign in cerebellar-type multiple system atrophy and spinocerebellar ataxia type 3
14. Utility of movement disorder society-unified Parkinson's disease rating scale for evaluating effect of subthalamic nucleus deep brain stimulation
15. Effects of bilateral pallidal deep brain stimulation on chorea after pulmonary thromboendarterectomy with deep hypothermia and circulatory arrest: a case report
16. Skin sympathetic function in complex regional pain syndrome type 1
17. Temporal characteristics of aspiration pneumonia in elderly inpatients: From resumption of oral intake to onset
18. The IGF Binding Protein Superfamily
19. DRD2 Taq1A Polymorphism-Related Brain Volume Changes in Parkinson’s Disease: Voxel-Based Morphometry
20. Dopaminergic Correlates of Regional Cerebral Blood Flow in Parkinsonian Disorders
21. Recurrent Cerebral Infarcts Associated with Uterine Adenomyosis: Successful Prevention by Surgical Removal
22. Diminished emotional sweating in patients with limbic encephalitis
23. Pareidolia in Parkinson’s Disease and Multiple System Atrophy
24. Differences in skin sympathetic involvements between two chronic autonomic disorders: Multiple system atrophy and pure autonomic failure
25. Role of intestinal peptides and the autonomic nervous system in postprandial hypotension in patients with multiple system atrophy
26. Cutaneous Sympathetic Dysfunction in Patients with Machado–Joseph Disease
27. Neurodegenerative disorders affecting the autonomic nervous system: Pure autonomic failure and multiple system atrophy
28. Neuropsychiatric Symptoms in Parkinson's Disease After Subthalamic Nucleus Deep Brain Stimulation
29. Measurements of sweat response and skin vasomotor reflex for assessment of autonomic dysfunction in patients with diabetes
30. FGFR3-related dwarfism and cell signaling
31. Neurodegenerative disorders affecting the autonomic nervous system: Pure autonomic failure and multiple system atrophy.
32. Clear cell injury associated with reduced expression of carbonic anhydrase II in eccrine glands consistently occurs in patients with acquired idiopathic generalized anhidrosis
33. Sustained phosphorylation of mutated FGFR3 is a crucial feature of genetic dwarfism and induces apoptosis in the ATDC5 chondrogenic cell line via PLCγ-activated STAT1
34. PTH has the potential to rescue disturbed bone growth in achondroplasia
35. Diminished skin vasodilator response to local heating in patients with long-standingsubacute myelo-optico-neuropathy
36. DRD2 Taq1A Polymorphism-Related Brain Volume Changes in Parkinson’s Disease: Voxel-Based Morphometry
37. Efficacy of growth hormone therapy for patients with skeletal dysplasia
38. Subthalamic deep brain stimulation can improve gastric emptying in Parkinson’s disease
39. Vertical pons hyperintensity and hot cross bun sign in cerebellar-type multiple system atrophy and spinocerebellar ataxia type 3
40. The vertical pons hyperintensity and hot cross bun sign in cerebellar-type multiple system atrophy and spinocerebellar ataxia type 3
41. Pyridostigmine in autonomic failure: can we treat postural hypotension and bladder dysfunction with one drug?
42. Skin vasodilator response to local heating in multiple system atrophy
43. Over 10 years of isolated autonomic failure preceding dementia and Parkinsonism in 2 patients with Lewy body disease
44. Characterization of Insulin-Like Growth Factor Binding Protein-3 (IGFBP-3) Binding to Human Breast Cancer Cells: Kinetics of IGFBP-3 Binding and Identification of Receptor Binding Domain on the IGFBP-3 Molecule*
45. Serum Free Insulin-Like Growth Factor I (IGF-I), Total IGF-I, and IGF-Binding Protein-3 Concentrations in Normal Children and Children with Growth Hormone Deficiency*
46. Improved self‐perceived performance for continence problems in patients with Parkinson's disease after deep brain stimulation
47. Urinary symptoms are correlated with quality of life after deep brain stimulation in Parkinson's disease
48. Postvoid residual predicts the diagnosis of multiple system atrophy in Parkinsonian syndrome
49. Long term follow-up on quality of life and its relationship to motor and cognitive functions in Parkinson's disease after deep brain stimulation
50. The Utility of Post-Void Residual Volume versus Sphincter Electromyography to Distinguish between Multiple System Atrophy and Parkinson’s Disease
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.